Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-19-002567
Filing Date
2019-05-10
Accepted
2019-05-10 17:16:25
Documents
71
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipix_10q.htm 10-Q 771538
2 OPINION OF GARY R. HENRIE, ESQ. ipix_ex51.htm EX-5.1 12007
3 OPINION OF HOGAN LOVELLS US LLP ipix_ex52.htm EX-5.2 8554
4 CERTIFICATION ipix_ex311.htm EX-31.1 7325
5 CERTIFICATION ipix_ex312.htm EX-31.2 7618
6 CERTIFICATION ipix_ex321.htm EX-32.1 2659
7 CERTIFICATION ipix_ex322.htm EX-32.2 2837
14 ipix_ex52img1.jpg GRAPHIC 7693
  Complete submission text file 0001477932-19-002567.txt   4477183

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ipix-20190331.xml EX-101.INS 693007
9 XBRL TAXONOMY EXTENSION SCHEMA ipix-20190331.xsd EX-101.SCH 75894
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20190331_cal.xml EX-101.CAL 50426
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20190331_def.xml EX-101.DEF 290036
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20190331_lab.xml EX-101.LAB 344039
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20190331_pre.xml EX-101.PRE 356589
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

EIN.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 19816007
SIC: 2834 Pharmaceutical Preparations